12 unknown. 12 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 12 | Unknown 12 |
| Phase 1 | 1 | Unknown 1 |
Follow gimeracil: new trials by email Literature Review of gimeracil trials Research Report on gimeracil
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Quintuple Method for Treatment of Multiple Refractory Colorectal Liver Metastases Oxaliplatin, S1, Cetuximab - For Patients With Colorectal Cancer Liver Metastases Who Were Not Able to Curative Surgical Resection.Focused on the Treatment Effect With the Quintuple Method | Phase 2 | Unknown | Liaoning Cancer Hospital & Institute | 100 | 2023-03-15 | 2023-03-20 |
| Fruquintinib Plus S-1 and Raltitrexed (RSF) for MCRC Fruquintinib, S-1, raltitrexed - Fruquintinib, S-1 | Phase 2 | Unknown | Meng Qiu | 66 | 2023-02-20 | 2025-01-22 |
| Effect and Safety of Envafolimab Combined With Endostar/S-1 in Second-line of Advanced Non-small Cell Lung Cancer Envafolimab plus Endostar and S-1, Envafolimab plus Endostar, Envafolimab plus S-1 - Carcinoma, Non-Small-Cell Lung | Phase 2 | Unknown | Anhui Chest Hospital | 45 | 2022-09-18 | 2022-09-07 |
| A Phase II Study of Gimatecan (ST1481) in Locally Advanced or Metastatic Pancreatic Cancer Gimatecan, tegafur, gimeracil and oteracil potassium, gemcitabine - Pancreatic Cancer | Phase 2 | Unknown | Lee's Pharmaceutical Limited | 60 | 2020-12-01 | 2020-10-01 |
| CCRT Followed by Tegafur, Gimeracil and Oteracil Potassium in Cervical Cancer Tegafur, Gimeracil and Oteracil Potassium Capsules (one drug) - Cervical Cancer, Chemotherapy | Phase 1 / Phase 2 | Unknown | Peking Union Medical College Hospital | 200 | 2020-04-15 | 2020-03-19 |
| Tripletrumab Combined With Oxaliplatin and Teggio (SOX) in First-line Treatment of Gastric and Gastroesophageal Junction Adenocarcinoma Toripalimab combined with oxaliplatin and Tegafur,Gimeracil and Oteracil Porassium Capsules - Gastric Cancer | Phase 2 | Unknown | RenJi Hospital | 20 | 2020-02-01 | 2019-12-17 |
| Apatinib Combined With SOX Neoadjuvant Therapy for Locally Advanced Gastric Cancer ApatinibMesylateTablets - Apatinib Combined, SOX | Phase 2 | Unknown | Chang-Ming Huang, Prof. | 50 | 2017-09-01 | 2020-02-05 |
| The Clinical Study of Apatinib Plus S1 for Patients With Advanced Non-squamous Head and Neck Cancer Apatinib, S1 - Head and Neck Neoplasms | Phase 2 | Unknown | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 30 | 2016-10-01 | 2016-10-24 |
| Combined Use of Raltitrexed and S-1 as Treatment for Patients With Metastasizing Colorectal Cancer Raltitrexed and S-1 - Metastatic Colon Cancer | Phase 2 | Unknown | Fudan University | 82 | 2015-12-25 | 2017-10-02 |
| Study of Oxaliplatin, Irinotecan, and S-1 in Biliary Tract Cancer Oxaliplatin, Irinotecan, S-1 - Biliary Tract Neoplasm | Phase 2 | Unknown | Hallym University Medical Center | 31 | 2015-03-01 | 2017-08-23 |
| DC-CIK In Combination With Chemotherapy ( Gio / Oxaliplatin or Cisplatin ) Versus First-line Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma Randomized Controlled Phase II Clinical Study of Treatment autologous dendritic cells co-cultured with cytokine-induced killer cells, Gimeracil and Oteracil Porassium Capsules, Oxaliplatin - Gastric Cancer | Phase 2 | Unknown | Beijing Biohealthcare Biotechnology Co.,Ltd | 80 | 2014-11-01 | 2015-07-21 |
| RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301). Laboratory test, Medical history and physical examination, BW and height - Rectal Cancer | Phase 2 | Unknown | Clinical Research Support Center Kyush | 110 | 2013-09-01 | 2014-10-31 |
Stomach Neoplasms (2) · Biliary Tract Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Colonic Neoplasms (1) · Head and Neck Neoplasms (1) · Pancreatic Neoplasms (1) · Rectal Neoplasms (1) · Uterine Cervical Neoplasms (1)
Anhui Chest Hospital (1) · Beijing Biohealthcare Biotechnology Co.,Ltd (1) · Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1) · Chang-Ming Huang, Prof. (1) · Clinical Research Support Center Kyush (1) · Fudan University (1) · Hallym University Medical Center (1) · Lee's Pharmaceutical Limited (1) · Liaoning Cancer Hospital & Institute (1) · Meng Qiu (1) · Peking Union Medical College Hospital (1) · RenJi Hospital (1)
China (7) · Japan (1) · South Korea (1)
Dae Young Zang, MD, PhD (1) · Ke Hu, MD (1) · Meng Qiu, MD. (1) · Wei Jian Guo, doctor (1) · Xiaohui He, B.D. (1) · Yasunori Emi, MD, PhD (1)
PMID 19331206, PMID 21183517, PMID 26884585, PMID 33567129, PMID 34241629, PMID 38022664, PMID 40022044